RedIA Salud
Spain has set out to strengthen a robust ecosystem for AI applied to health, accelerating the transfer of knowledge, the maturity of digital solutions, and the international positioning of the country’s health-technology sector. To achieve this, the Government of Spain has launched the RedIA Salud program through Red.es and the State Secretariat for Digitalization and Artificial Intelligence. This initiative, co-funded by the European Regional Development Fund (ERDF 2021–2027), has a budget of 50 million euros to promote the adoption of AI in the healthcare sector.
RedIA Salud supports companies of any size (large enterprises, SMEs, startups) with projects that apply advanced AI technologies in the health domain. These projects may be carried out individually or in collaboration with health services, hospitals, universities, research centers, patient associations, or healthcare professionals. Each proposal must include a demonstration, validation, or certification with real-world data, ensuring that AI solutions operate under realistic conditions. The aim of the program is to speed up the safe and effective deployment of AI in the healthcare system, fostering sustainable innovation and public-private cooperation.
Each project may request funding between €400,000 and €5,000,000, with coverage ranging from 25% to 60% of eligible costs. Applications may address a wide range of health-related areas such as: assisted diagnosis, personalized medicine, health-system management, emergency response, biomedical or pharmacological research, among others.
Key Aspects of the RedIA Salud 2025 Call
Submission deadline: Until January 5, 2026.
Execution period: Up to 24 months from the publication of the grant award resolution.
Funding intensity:
Up to 60% for small companies.
Up to 50% for medium-sized companies.
Up to 40% for all other entities.
Minimum grant amount: €400,000.
Advance payment: An advance of 40% of the grant amount may be requested (with guarantees covering that amount).
Participants: The project must include the effective participation of the agents required for proper execution.
Focus: AI solutions validated with real-world data.
What makes BIOINFILE a strategic partner?
Thanks to its expertise in Data-as-a-Service (DaaS) and AI-driven biomedical data curation, BIOINFILE positions itself as an ideal partner for RedIA Salud participants. Through its continuously curated and updated biomedical and microbiome databases, BIOINFILE provides teams with solid datasets and the scientific rigor required to train and validate AI models in real clinical settings. See a real Use Case here.
By combining advanced AI algorithms with deep scientific knowledge, BIOINFILE delivers accurate, ready-to-use datasets, significantly reducing the time and effort needed for data preparation. Its scalable data-management approach allows these curated datasets to be integrated smoothly into R&D projects, speeding up the development and validation of healthcare-AI solutions. See how open innovation can benefit your ROI.
BIOINFILE prescribes quality data, following the FAIR (Findable, Accessible, Interoperable, Reusable) and FATE (Fairness, Accountability, Transparency, Explicability) principles, ensuring that every project remains solid from both a scientific and ethical perspective. At the same time, its sustainable data practices, focused on efficient resource usage and reducing redundancies, help shorten R&D timelines while lowering the environmental footprint of biomedical innovation.
By collaborating with BIOINFILE, organizations gain access to ethically curated and validated data, as well as a reliable partner capable of turning AI-driven health initiatives into robust and sustainable solutions.
